ARCHIVES

Wyden Asks Healy To Clarify CRADA Pricing Clause

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

February 18, 2005

DFA Proposes Controversial Guidelines For Clinical Tests

November 21, 1975

List Of NCI Divisions, Addresses And Telephone Numbers

October 13, 1995

ICCCR Participants Honor Cullen, Blast Tobacco Industry

March 15, 1991

C. Gordon Zubrod, 84, Dies, Led Chemotherapy Research, Built Cooperative Group System

January 29, 1999

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992